WPD21_WEB_Header_Desktop_2000x850px.jpg

Shedding Light on Psoriasis

Header

Shedding Light on Psoriasis

Psoriasis is one of the most prevalent skin conditions in the world and it poses a significant burden in the day-to-day life of 71% of patients1. The disease also affects the overall emotional wellbeing of 88% of them2. These patients perceive that their relationship with healthcare professionals is linked not only to the management of their disease, but also to their happiness and wellbeing2.

Almirall's campaign for this global awareness event, #SheddingLightOnPsoriasis, is in support of the annual International Federation of Psoriasis Associations (IFPA) World Psoriasis Day.

We invite you to join us and participe in our campaign by raising awareness on psoriasis in your community.

Spread the word and share on social media

Help us raise awareness by sharing these images using the hashtag #SheddingLightOnPsoriasis

IFPA's World Psoriasis Day 2021 Campaign

Almirall is proud to sponsor this year's IFPA's awaress campaign: Uniting for action.

"Since the first World Psoriasis Day, we have won many great victories for our psoriatic disease community. Still, people with psoriatic disease continue to face many unmet needs. United, we seize the opportunity of World Psoriasis Day to take action."

The voice of over 60 million people living with psoriasis

For World Psoriasis Day 2021, the psoriatic disease community unites to demand action. IFPA is spearheading a world psoriasis day petition. By getting involved now, we can all spark action.

We invite you to sign the World Psoriasis Day Petition, United - Now Act in the IFPA website to demand breakthroughs in multi-disciplinary care and equal access to treatment; to demand change in the perception of psoriatic disease among the medical community to stop stigma, and to fight for everyone living with every kind of psoriatic disease.

More information: IFPA | World Psoriasis Day

 

How does psoriasis affect my wellbeing?

One of three people still believe that psoriatic disease affects only the skin3 but statistics show that it does affect the whole body, also the mental health of the patient, and impacts directly on the quality of life and wellbeing. In fact, 98% of patients report that psoriasis has an impact on their emotional life4.

People living with psoriasis are at higher risk of developing anxiety and depression due to the disease and because of the effect of the inflammation of the brain2.

According to the World Psoriasis Happiness Report 20181, only 27% of the patients report that their doctor refers to their mental health while treating the skin disease, whereas nearly 50% of psoriasis patients state that their healthcare professionals have no understanding of how the disease affects their mental health.

The voice of patients

Rocyie, Joel and Hellen have psoriasis, and in these videos, they tell us about their lives with this chronic disease. They explain how psoriasis affects their wellbeing and quality of life and tell us about the daily challenges they face.

Our commitment to Psorasis’ patients

 

 

Mahil, S., et al. "The impact of the COVID-19 pandemic on people with psoriasis: findings from a global patient-reported registry." British Journal of Dermatology (2021): 8-8.

 

 

 

 

Psoriasis and COVID-19

Having psoriatic disease and one or more comorbidities takes a physical, psychological, and financial toll on individuals. As the COVID-19 pandemic unfolded, it became clear that some of the common psoriatic disease comorbidities are risk factors of poor outcomes from COVID-19, adding oen more potential risk burden.

 

43% of people living with psoriatic disease have seen their disease become worse during the COVID-19 pandemic.

References

1. National Psoriasis Foundation 2008 Survey Snapshot. Available from: http://www.psoriasis.org/document.doc?id=193

2. Armstrong AW, Schupp C, Wu J, et al. PLoS One. 2012;7(12):e52935; 2. National Psoriasis Foundation 2008 Survey Snapshot. Available from: http://www.psoriasis.org/document.doc?id=193.; 3. Krueger G, Koo J, Lebwohl M, et al. Arch Dermatol. 2001;137(3):280-284.

3. Source: International Federation of Psoriasis Associations. Oct 2021. https://ifpa-pso.com/

4. World Health Organization. 2016. Global report on PSORIASIS available at http://apps.who.int/iris/bitstream/10665/204417/1/9789241565189_eng.pdf